Lymphoma Research Foundation’s Scientific Leadership and Investment in Innovative Research Highlighted Throughout 2015 ASH Annual Meeting

Share Article

57th American Society of Hematology Annual Meeting Features Research of LRF Scientific Advisory Board Members and Grantees

The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – is proud to have members of its prestigious Scientific Advisory Board and research grantees present innovative and promising research at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition.

Each year, the ASH Annual Meeting seeks to provide a critical forum for leading hematologists / oncologists to present their findings to over 20,000 of their peers, in what has become one of the leading events in the clinical research community. This year, ASH will feature over 20 groundbreaking abstracts proceeding from research funded by the Lymphoma Research Foundation, as a part of LRF’s innovative research portfolio.

“The Lymphoma Research Foundation’s commitment to advancing the field of lymphoma research through its investment in the most promising lymphoma research is highlighted through its breadth of reach at ASH,” said Dr. Leo I. Gordon, Chair of the LRF Scientific Advisory Board. “LRF continues to work with the best scientists in the field and invest in the research projects that have the greatest potential to impact and improve the treatment and understanding of lymphoma.”

Current members of LRF’s Scientific Advisory Board, which is comprised of 45 world-renowned lymphoma experts and guides LRF research activities, will account for 17 unique abstract presentations on lymphoma and be represented in the findings of nearly 170 total abstracts at ASH.

“The Lymphoma Research Foundation is proud to work with the leading lymphoma experts, researchers and clinicians and to support research projects that are not only at the forefront of research, but have the greatest potential to improve patient care and treatment options,” said Meghan Gutierrez, LRF Chief Executive Officer. “The Foundation’s unique investment in young investigators and partnerships with scientific leaders can be seen through this year’s ASH presentations.”

The Lymphoma Research Foundation remains uniquely committed to funding the brightest young minds in hematology research in the early stages of their careers in an effort to keep the top minds in clinical research focused on lymphoma through its Clinical Research Mentoring Program (LCRMP). This year’s class of eight “LRF Scholars” will account for 12 innovative presentations on lymphoma-related topics at this year’s meeting.

Throughout this year’s ASH Annual Meeting, members of the Lymphoma Research Foundation Executive Team will be available for comment on ongoing ASH presentations and findings. For requests for real-time comment, please contact Peggy Ann Torney, Senior Director of Strategy and Communications, at ptorney(at) or (646) 300-5506.

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $57 million in lymphoma-specific research. For additional information on LRF’s research, education and services, visit


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jake DiGregorio
Visit website